Lumbosacral polyradiculoneuropathy associated with combination therapy of nivolumab and ipilimumab
Lumbosacral polyradiculoneuropathy associated with combination therapy of nivolumab and ipilimumab
Citations

WEB OF SCIENCE

0
Citations

SCOPUS

0

초록

Immune checkpoint inhibitors (ICIs) have emerged as one of the most promising therapeutic options for advanced cancers. While ICIs have improved survival in multiple cancers, their in- creased use is restricted by various immune-related adverse events. In this report we describe a patient with renal cell carcinoma who received a combination of ICIs, nivolumab plus ipilim- umab, and who developed lumbosacral polyradiculoneuropathy. Corticosteroid use was an effective treatment for this patient.

키워드

PolyradiculoneuropathyDrug-related side effectsImmune checkpoint inhibitors
제목
Lumbosacral polyradiculoneuropathy associated with combination therapy of nivolumab and ipilimumab
제목 (타언어)
Lumbosacral polyradiculoneuropathy associated with combination therapy of nivolumab and ipilimumab
저자
Eun Bin ChoSeung Joo KimTae Won YangSeunguk JungHeejeong JeongKi-Jong Park
발행일
2022-04
저널명
Annals of Clinical Neurophysiology
24
1
페이지
26 ~ 29